Ascent Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Buy |
14,121
+97
| +0.7% | +$11.7K | 0.07% | 239 |
|
|
2025
Q1 | $1.56M | Buy |
14,024
+7,176
| +105% | +$800K | 0.07% | 263 |
|
|
2024
Q4 | $666K | Buy |
6,848
+157
| +2% | +$15.3K | 0.05% | 330 |
|
|
2024
Q3 | $770K | Buy |
6,691
+275
| +4% | +$31.6K | 0.06% | 318 |
|
|
2024
Q2 | $683K | Buy |
6,416
+345
| +6% | +$36.7K | 0.06% | 316 |
|
|
2024
Q1 | $587K | Sell |
6,071
-189
| -3% | -$18.3K | 0.05% | 328 |
|
|
2023
Q4 | $629K | Sell |
6,260
-289
| -4% | -$29.1K | 0.06% | 308 |
|
|
2023
Q3 | $611K | Sell |
6,549
-582
| -8% | -$54.3K | 0.07% | 291 |
|
|
2023
Q2 | $735K | Sell |
7,131
-98
| -1% | -$10.1K | 0.08% | 268 |
|
|
2023
Q1 | $665K | Sell |
7,229
-29
| -0.4% | -$2.67K | 0.07% | 275 |
|
|
2022
Q4 | $658K | Buy |
7,258
+48
| +0.7% | +$4.36K | 0.08% | 268 |
|
|
2022
Q3 | $585K | Buy |
7,210
+597
| +9% | +$48.4K | 0.07% | 268 |
|
|
2022
Q2 | $568K | Buy |
6,613
+407
| +7% | +$35K | 0.07% | 281 |
|
|
2022
Q1 | $545K | Buy |
6,206
+2,999
| +94% | +$263K | 0.06% | 285 |
|
|
2021
Q4 | $279K | Buy |
+3,207
| New | +$279K | 0.04% | 387 |
|